Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 1;14(3):e2024215.
doi: 10.5826/dpc.1403a215.

Comparative Analysis of Intralesional Immunotherapy and Conventional Treatments for Non-Genital Warts: A Systematic Review and Network Meta-Analysis

Affiliations
Review

Comparative Analysis of Intralesional Immunotherapy and Conventional Treatments for Non-Genital Warts: A Systematic Review and Network Meta-Analysis

Amr Molla et al. Dermatol Pract Concept. .

Abstract

Introduction: Warts, benign skin growths caused by various human papillomavirus strains, are categorized as genital and non-genital. Non-genital warts often lack noticeable symptoms but can lead to psychological distress due to factors like embarrassment. Traditional treatments, including physical and chemical methods, show limitations, prompting the exploration of novel approaches like intralesional immunotherapy. The clinical challenge lies in selecting the most effective modality.

Objective: In our study, we used the network meta-analysis (NMA) as a statistical tool to explore the most effective intralesional immunotherapy interventions.

Methods: Comprehensive searches of Web of Science, PubMed, Cochrane, and Scopus databases were conducted until December 2023. Eligible studies were analyzed for outcomes presented as risk ratios (RRs) with 95% confidence intervals (CI). Treatments were ranked using the P-score in an NMA performed with R software.

Results: We included 68 RCTs in our study. For complete response, needling showed a significant difference compared to Candida albicans antigen (RR= 0.13, 95% CI [0.02; 0.99]) and Mw (RR= 0.12, 95% CI [0.02; 0.94]). In overall response, both bleomycin and furosemide with digoxin were significant compared to autoimplantation (RR= 0.46, 95% CI [0.24; 0.88]) and (RR= 0.40, 95% CI [0.18; 0.91]) respectively. Similarly, both were significant compared to cryotherapy (RR= 0.45, 95% CI [0.27; 0.76]) and (RR= 0.40, 95% CI [0.19; 0.82]) respectively.

Conclusion: This NMA indicates needling, furosemide with digoxin, and PBP antigen stimulants as effective for non-genital warts, surpassing traditional treatments in complete and overall response. Direct comparisons in future research are warranted to confirm their superiority.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None.

Figures

Figure 1
Figure 1
PRISMA flow chart.
Figure 2
Figure 2
Risk of bias summary graph of the included randomized control trials.
Figure 3
Figure 3
Complete response: (A) Network graph showing direct evidence between the evaluated interventions. (B) A forest plot comparing all interventions. (C) The league table represents the network meta-analysis estimates for all interventions’ comparisons.
Figure 4
Figure 4
Overall response: (A) Network graph showing direct evidence between the evaluated interventions. (B) A forest plot comparing all interventions. (C) The league table represents the network meta-analysis estimates for all interventions’ comparisons.
Figure 5
Figure 5
No or minimal response: (A) Network graph showing direct evidence between the evaluated interventions. (B) A forest plot comparing all interventions. (C) The league table represents the network meta-analysis estimates for all interventions’ comparisons.
Figure 6
Figure 6
Partial response: (A) Network graph showing direct evidence between the evaluated interventions. (B) A forest plot comparing all interventions. (C) The league table represents the network meta-analysis estimates for all interventions’ comparisons.

Similar articles

Cited by

References

    1. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12–F23. doi: 10.1016/j.vaccine.2012.07.055. - DOI - PubMed
    1. Rowson KE, Mahy BW. Human papova (wart) virus. Bacteriol Rev. 1967;31(2):110–131. doi: 10.1128/br.31.2.110-131.1967. - DOI - PMC - PubMed
    1. Kuriyama Y, Kosaka M, Kaneko A, et al. Skin surface material for detecting human papillomavirus infection of skin warts. J Dermatol. 2023;50(11):1450–1458. doi: 10.1111/1346-8138.16920. - DOI - PubMed
    1. Jabłońska S, Majewski S, Obalek S, Orth G. Cutaneous warts. Clin Dermatol. 1997;15(3):309–319. doi: 10.1016/s0738-081x(96)00170-8. - DOI - PubMed
    1. Tosti A, Piraccini BM. Warts of the nail unit: surgical and nonsurgical approaches. Dermatol Surg. 2001;27(3):235–239. - PubMed

LinkOut - more resources